Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa
Clinical trial NCT03578029 · TERMINATED
Trial details
- NCT number
- NCT03578029
- Sponsor
- Lenus Therapeutics, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-22
- Primary completion
- 2021-09-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.